(Q55464876)

12 July 2018

title

Efficacy and safety of miltefosine in treatment of post-kala-azar dermal leishmaniasis. (English)

1 reference

12 July 2018

main subject

visceral leishmaniasis

1 reference

1 reference

1

Shyam Sundar

1 reference

12 July 2018

Anup Singh

2

1 reference

12 July 2018

Jaya Chakravarty

series ordinal

3

1 reference

12 July 2018

Madhukar Rai

series ordinal

4

1 reference

12 July 2018

language of work or name

English

0 references

publication date

1 January 2015

1 reference

12 July 2018

The Scientific World Journal

published in

1 reference

12 July 2018

volume

2015

1 reference

12 July 2018

page(s)

414378

1 reference

12 July 2018

Creative Commons Attribution 3.0 Unported

copyright license

start time

1 January 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Enhanced case detection and improved diagnosis of PKDL in a Kala-azar-endemic area of Bangladesh

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4313722

Evaluation of PCR for diagnosis of Indian kala-azar and assessment of cure

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4313722

Post-kala-azar dermal leishmaniasis.

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4313722

Oral miltefosine for Indian visceral leishmaniasis

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4313722

Trial of oral miltefosine for visceral leishmaniasis

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4313722

Amphotericin B is superior to sodium antimony gluconate in the treatment of Indian post-kala-azar dermal leishmaniasis

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4313722

Efficacy of prolonged therapy with stibogluconate in post kala-azar dermal leishmaniasis

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4313722

Implementation research to support the initiative on the elimination of kala azar from Bangladesh, India and Nepal--the challenges for diagnosis and treatment

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4313722

Miltefosine as an effective choice in the treatment of post-kala-azar dermal leishmaniasis

12 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1155%2F2015%2F414378

Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25685839

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1155/2015/414378

1 reference

12 July 2018

PMC publication ID

4313722

1 reference

12 July 2018

PubMed publication ID

25685839

1 reference

12 July 2018